Retropharyngeal lymph node metastases in head and neck malignancies

There is no fulltext present in this item.

Title:	Retropharyngeal lymph node metastases in head and neck malignancies
Author(s):	Coskun, H.H.; Ferlito, A.; Medina, J.E.; Robbins, K.T.; Rodrigo, J.P.; Strojan, P.; Suarez, C.; Takes, R.P. ; Woolgar, J.A.; Shaha, A.R.; Bree, R. de; Rinaldo, A.; Silver, C.E.
Publication year:	2011
Source:	Head and Neck-Journal for the Sciences and Specialties of the Head and Neck, vol. 33, iss. 10, (2011), pp. 1520-1529
ISSN:	1043-3074
DOI:	https://doi.org/10.1002/hed.21526
Publication type:	Article / Letter to editor
Please use this identifier to cite or link to this item : http://hdl.handle.net/2066/98314
Display more details
Subject:	ONCOL 5: Aetiology, screening and detection
Organization:	Otorhinolaryngology
Journal title:	Head and Neck-Journal for the Sciences and Specialties of the Head and Neck
Volume:	vol. 33
Issue:	iss. 10
Page start:	p. 1520
Page end:	p. 1529
Abstract:	Retropharyngeal lymph node (RPLN) metastasis of primary head and neck cancer often receives less consideration than lymph node metastasis in the neck. With improvements in imaging techniques and reports of surgical pathology, there is an improved understanding of the risk and subsequently the need for treatment of RPLNs. The rates of RPLN metastasis from carcinomas of the nasopharynx, oropharynx, hypopharynx, postcricoid region, maxillary sinus, and cervical esophagus are sufficiently high to warrant routine treatment, either electively or therapeutically, of this region. Through improved diagnostic techniques and heightened awareness of RPLN metastasis, patients at risk of having these metastases can be treated more effectively.